2 Marijuana Penny Stocks to Watch

best marijuana penny stocks

Investing in penny stocks can often prove to be highly rewarding and if the stock in question belongs to a high growth sector then the chances of a significant return rise manifold. When a sector is still nascent then there is always a chance for smaller companies to grow.

penny pot stocks

That opens up an opportunity for those who want to invest in penny stocks. One such sector is the marijuana sector. It’s only a few years old and there are still plenty of small companies that have the potential to turn into large ones. Here is a look at two marijuana penny stocks one should track.

Marijuana Penny Stocks to Watch #2 OrganiGram Holdings

The first company to consider in this regard is OrganiGram Holdings Inc. (OGI), which has remained under the radar over the past months despite making some very impressive moves as a business. One of the more important factors in favor of OrganiGram is the fact that it is the only major marijuana grower in Eastern Canada.

marijuana penny stocks

That could give it the chance of dominating that market. It is interesting to note that despite the lower population, it has a higher percentage of marijuana consumers when compared to the Canadian national average.

Additionally, the company’s production capabilities are set to be enhanced. OrganiGram expects that it will be able to produce 100,000 kilos a year when at full capacity. The company claims that it’s going to yield 250 grams per square feet. This is significantly higher than the 75 grams per square feet that is being produced by most of its rivals. The legalization of edibles and other derivatives in Canada later on this year is another opportunity that could fuel the next stage of growth for OrganiGram.

5 Penny Stocks To Add To Your List In October

Marijuana Penny Stocks to Watch #2 MediPharm Labs

The other promising company in this respect is MediPharm Labs (LABS) (MEDIF), which has a lot of potentials and is involved in a very specialized space. The company is involved in processing and packaging hemp or marijuana extracts for other companies, which are then used for other purposes. MediPharm has become one of the leaders of that particular industry and has locked up some lucrative contracts with some of the leading marijuana producers.

It has inked a contract with plenty of producers, but its most significant contract is with Cronos Group. It has an 18-month deal in which it will supply Cronos with $30 million worth of concentrates and there is an option to double it to $60 million over a two year period as well. It started is extraction services only last November and has already become an industry leader.

4 Cannabis Stocks With Recent News

The legal cannabis market is predicted to hit USD $146.4 billion globally by 2025, according to a report by Grand View Research. This rapid growth is propelled by increased cannabis legalization seen around the globe as well as the growing use of cannabis in several medical applications.

marijuanastocks.jpg

As far as the stock market is concerned, legal recreational cannabis will account for as much as 61% of the industry overall, with the other 39% going to medicinal cannabis as well as the black market. Despite this, many cannabis stocks have been able to make quite a name for themselves given the massive amount of momentum and propensity toward future growth that the cannabis industry has shown over the last few years.

Leafbuyer Technologies, Inc. (LBUY)a leading cannabis technology and marketing platform, announced the launch of its innovative delivery technology to complement its mobile application. This week a preliminary beta launch will begin to include that dispensaries in states such as California, Arizona, Nevada, and Washington are now able to add delivery to their list of offerings through Leafbuyer’s Greenlight mobile app.

“The addition of this new technology will allow us to monetize our consumer base through a fee generated from each transaction,” said Kurt Rossner, CEO. “We’ll be able to penetrate thousands of new dispensaries and delivery companies in legal markets by offering this delivery solution. Leafbuyer will not physically deliver the products, rather we will hand off the ‘last mile’ to our delivery and dispensary partners.”

Leafbuyer reported that its quarterly cash sales growth increased 36% year over year in the quarter ending March 31, 2019, attributing its growth to platform enhancements. The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at numerous participating dispensaries, and now delivery. The company recently launched a Los Angeles satellite office, which will become the primary regional office for several Western states, allowing sales initiatives to be more heavily focused on newly legal Midwestern and Eastern states.

Aphria Inc. (APHA), a Canadian cannabis company, announced it has closed its private placement offering of $300 million of 5.25% convertible senior notes due 2024 and that initial purchasers fully exercised their option to buy up to an additional $50 million of notes, resulting in gross proceeds of $350 million.  The company plans to use the net proceeds to support its international expansion initiatives, for future acquisitions as well as general corporate purposes.

This followed the news that its German subsidiary Aphria Deutschland GmbH has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices and was granted a cultivation license for four of the nine total lots awarded.

“Aphria thanks the BfArM for their diligent examination and validation of our approach for domestic cultivation with this license,” said Hendrik Knopp, Managing Director of Aphria Germany. “Construction on our 8,000 square meter indoor cultivation facility is already underway and we anticipate it will be fully operational by Summer 2020. We are pleased to additionally support German patients in the upcoming months with high-quality imported cannabis flower and oils from Denmark and Canada.”

Aurora Cannabis Inc. (ACB), a world leading cannabis company, announced its contract with the German Federal Institute for Drugs and Medical Devices has been finalized allowing Aurora to begin construction on a new state of the art indoor cannabis production facility this May.

“We are thrilled with the positive outcome of the tender process, and excited to start construction on our latest production facility,” said Neil Belot, Chief Global BDO. “In addition to providing German medical patients with a local supply of high-quality, medical grade cannabis, this new facility will also bring additional new jobs to the German labour market. It’s a strong validation of our production and distribution standards to have been recognized as having the highest-rated overall concept out of 79 tender applications, and we look forward to continuing to increase availability of medical cannabis in this important market.”

This news followed the company entering a binding letter agreement with Hempco Food and Fiber Inc. (HEMP), a provider of hemp-based foods, fiber and nutraceuticals.  The agreement entails that Aurora will acquire all of the issued and outstanding common shares, not already owned, of Hempco at$1.04 per share in common shares of Aurora, for a valuation of C$63.4 million.

Canopy Growth Corporation (CGC) (WEED), a world-leading diversified cannabis and hemp company, announced last week it would acquire US cannabis company Acreage Holdings, Inc. (ACRGF) in a $3.4 billion cash and stock deal that will close if and when cannabis production and sales are legal at the federal level in the US.

“Today we announce a complex transaction with a simple objective,” Co-Chief Executive Bruce Linton said. “Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally permissible pathway exists. By combining Acreage’s management team, licenses and assets with Canopy Growth’s intellectual property and brands, there will be tremendous value creation for both companies’ shareholders.”

Following the news of this potential deal, a GMP Securities’ analyst upgraded Canopy Growth from Hold to Buy with a price target raised from $65 to $72.

marijuana.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam owned 77,000 shares of Leafbuyer Technologies. Midammay buy or sell additional shares of (LBUY) in the open market at any time (as of 3/29/2019) Midam Ventures no longer owns 77,000 shares of (LBUY), including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

4 Cannabis Stocks Heating Up The Markets

The cannabis sector gained one if its biggest votes of confidence to date when top Wall Street firm Bank of America -Merrill Lynch initiated coverage on four of the top cannabis stocks with mostly positive outlook for sector.  BofA is the latest of the Wall Street firms to add cannabis to their coverage, following the likes of Cowen, Jefferies and Piper Jaffray.

cannabisstocks.jpg

Cannabis stocks, for the most part, have started the year off on a strong foot with the Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF), the largest and most representative cannabis exchange traded fund, up about 45%.  As the cannabis sector continues to break new boundaries, investors seeking opportunities in the budding sector may benefit from keeping tabs on several cannabis stocks.

Leafbuyer Technologies, Inc. (LBUY), a leading cannabis technology and marketing platform that connects consumers to dispensaries and product companies, announced the establishment of the company’s first satellite office in Los Angeles, California. The new office is in addition to its original Denver Colorado headquarters and will become the primary regional office for several western states. This move will help Leafbuyer expand its national footprint by enabling sales initiatives to focus on newly legal Midwestern and Eastern states.

“California is now a mature recreational and medical cannabis market, which makes this the opportune time to establish a secondary operation in the southern part of this industry-leading state,” said Kurt Rossner, CEO.

Leafbuyer recently announced that its quarterly cash sales growth rose 36% year over year in the quarter ending March 31, 2019. The cannabis stock attributes this success to platform enhancements, order ahead and Leafbuyer loyalty as well as a multi-state sales team.  The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at numerous participating dispensaries Leafbuyer plans to continue to expand its reach into newly legal US markets, while increasing consumer retention to boost bottom line revenues.

Canopy Growth Corporation (CGC) (WEED), a world-leading diversified cannabis and hemp company, is rumored to be preparing to purchase Acreage Holdings Inc, a U.S. cannabis company, by buying the right to purchase, according to Bloomberg and CNBC.  If Canopy Growth was to acquire the US-based cannabis company now, it would be delisted from the TSE since cannabis is illegal in the U.S., and the exchange does not allow companies to own stakes in businesses that run illegal operations.  Instead, Canopy Growth will purchase the rights to buy Acreage if or when cannabis becomes legal in the U.S. at an agreed-upon price, according to the source.

Bank of America (BAC) initiated new coverage Canopy Growth giving it a buy rating with a price target of $52.  On Tuesday, Co-CEO Bruce Linton updated the company’s revenue guidance at a cannabis conference in Toronto in which Canopy is anticipating at least $744 million in revenue in fiscal 2020, beating analyst estimates by 19 percent. The company also announced the completion of an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L. (Cafina). The acquisition paves the way for Canopy to expand its European production footprint.

“Operating multiple production assets within Europe will allow us to increase revenue in the EU free of supply constraints,” commented Mark Zekulin, President & Co-CEO. “This strategic acquisition in a scalable, low-cost production environment diversifies our owned production capabilities in Europe, similar to our approach in Canada where we have production facilities in seven different provinces. Adding Cafina will allow us to quickly build out our presence in Spain using its existing cultivation licence as a launch pad, while ensuring our Canadian footprint – the largest in the world – can continue to serve the medical and recreational needs of Canadians.”

HEXO Corp (HEXO), consumer packaged goods cannabis company, had Bank of America (BAC) initiated coverage on the stock giving it a buy rating and the title of its top cannabis stock pick.  Most recently, the company announced reaching a significant milestone of completing the first harvest in its 1 million sq. ft. expansion.

“Completing the first harvest in our 1,000,000 sq. ft. greenhouse expansion showcases the dedication and hard work of the entire HEXO team,” said Sébastien St-Louis, CEO and co-founder. “We are very proud of our continued ability to execute on our plans, creating value for our shareholders and demonstrating our commitment to our customers. This cultivation milestone means that an expanded HEXO product offering will be available to more Canadians shortly.”

In mid-March, HEXO announced a definitive arrangement agreement to acquire Newstrike Brands Ltd. (NWKRF) in a stock deal valued C$263 million ($196.7 million). This acquisition which will boost HEXO’s production capacity to 150,000 kg annually while increasing its domestic market access to 9 provinces.

Aurora Cannabis Inc. (ACB), a world leading cannabis company, also had Bank of America (BAC) initiate coverage on it stock giving it a buy rating and price target of $11. The company announced that, further to its April 5th press release, the public appeal process related to the German cannabis production tender has been completed, and Aurora’s contract with the German Federal Institute for Drugs and Medical Devices has been finalized allowing Aurora to begin construction on a new indoor cannabis production facility in May.

“We are thrilled with the positive outcome of the tender process, and excited to start construction on our latest production facility,” said Neil Belot, Chief Global Business Development Officer. “We are very proud of the work done by our European team.  In addition to providing German medical patients with a local supply of high-quality, medical grade cannabis, this new facility will also bring additional new jobs to the German labour market. It’s a strong validation of our production and distribution standards to have been recognized as having the highest-rated overall concept out of 79 tender applications, and we look forward to continuing to increase availability of medical cannabis in this important market.”

Also this week, Aurora announced entering a binding letter agreement with Hempco Food and Fiber Inc. (HEMP), a provider of hemp-based foods, fiber and nutraceuticals.  Per the agreement, Aurora will acquire all of the issued and outstanding common shares not already owned of Hempco and pay $1.04 per share in common shares of Aurora, for a valuation of C$63.4 million.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam owned 77,000 shares of Leafbuyer Technologies. Midammay buy or sell additional shares of (LBUY) in the open market at any time (as of 3/29/2019) Midam Ventures no longer owns 77,000 shares of (LBUY), including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

4 Marijuana Stocks To Watch This Week

The Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF) is the largest and most representative marijuana exchange traded fund in the markets. The fund strives to duplicate, to an extent, the performance of the North American Marijuana Index (NAMI). The NAMI was designed to track the performance of a basket of North American life sciences companies with a focus of their operations in the marijuana industry.

marijuana.jpg

Marijuana stocks, for the most part, have started the year off on a strong note as this marijuana ETF has risen 45% year to date.  As lawmakers advocate for legislative changes in favor of marijuana legalization and the adoption of marijuana for medical purposes rises, the sector has responded favorably.  Investors seeking opportunities in th budding  marijuana sector may benefit from keeping tabs on several marijuana stocks.

Leafbuyer Technologies, Inc. (LBUY), a leading cannabis technology and marketing platform that connects consumers to dispensaries and product companies, announced that its quarterly cash sales growth rose 36% year over year in the quarter ending March 31, 2019. The company attributes this success to mainly to platform enhancements, order ahead and Leafbuyer loyalty as well as a multi-state sales team.  The company’s go forward plan is to continue to expand into newly legal US markets, while increasing consumer retention to boost bottom line revenues.

“This growth provides momentum and a solid foundation for 2019. As we increase our national footprint and expand our industry leading platform, we’re forecasting significant sales gains through the remainder of the year,” said Kurt Rossner, CEO.

Last month. Leafbuyer announced that the number of its Greenlight platform users has reached nearly 80,000.  The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at participating dispensaries. At the time of this news release, the number of Leafbuyer dispensary clients with capabilities grew to 60 dispensaries, located throughout the states of California, Colorado, Oklahoma, and Michigan.

Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the health & wellness, announced that it has been working to resolve its 9.5% convertible notes due April 2019 and intends to repay the notes with cash from a business transaction as well as the net proceeds of a planned equity investment from long-term investor Foris Ventures.

“We are pleased with the support of our long term investors in supporting our plans to pay off this debt,” said John Melo, Amyris President and CEO. “We believe this pathway toward retiring our April 2019 debt should mitigate some of the dilutive impact on equity and we will provide more details and an update when this process is complete.”

At the end of March, Amyris announced stated it will discuss at an April 15 conference its previously disclosed cannabinoid development, licensing and commercialization agreement containing $300 million of R&D and milestone payments and a long-term royalty stream. Since, the company reached its first milestone for its cannabinoid partner, LAVVAN. They brought in the first payment of $10 million, which is part of a $300 million collaboration before future royalty payments.

Aphria Inc. (APHA) , a leading global cannabis company, announced fiscal third-quarter earnings reporting a loss as the company booked a C$58 million impairment charge and an additional C$30 million in operating losses. For the quarter ended Feb. 28th, Aphria reported a loss of $0.20 per share, compared to earnings of $0.08 per share for the year earlier.  However, the company reported that total revenue grew by 617% to $73.6 million compared to the $10.3 million the year prior.

“Our organization has experienced significant change in a very short period of time which was necessary to propel the Company forward. Aphria will continue to drive sustainable long-term shareholder value by leveraging its strong brand positioning, superior distribution model, product innovation, industrial scale cultivation and automation, medical-use leadership and strategic global platform” stated Irwin D. Simon, Chairman and Interim CEO.

The company also provided an update that it has entered into a series of transactions that will accelerate the expiration of an unsolicited takeover offer from Green Growth Brands to April 25. The transactions will provide up to an additional $89 million of liquidity without dilution to shareholders, according to the company.

Aurora Cannabis Inc. (ACB), a world leading cannabis company, provided an update on the status of Aurora Sun, the company’s latest and largest Sky Class facility which is currently under construction in Alberta. Aurora Sun will now be expanded by 33% from its original plans totaling to 1.62 million square feet to meet consumer demands. Aurora projects an expected production capacity at Aurora Sun in excess of 230,000 kg of high-quality cannabis annually.

“Aurora Sun represents the next evolution in our Sky Class facility design, delivering massive scale, low cost production, and consistent, high-quality cannabis,” said Terry Booth, CEO. “The increased scale of Aurora Sun reflects our expectations for the long-term growth in global demand, especially the higher margin international medical markets which will be faced with significant supply shortages for the foreseeable future. Sun is also designed with flexibility in mind to enable us to quickly meet changing market demands, particularly as breeding and cultivation technologies evolve and as customer preferences and requirements change.”

cannabisstocks1.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc.. Click here for full Midam disclaimer.

Today’s Trending Cannabis Stocks

The cannabis industry is projected to grow to $50 billion by 2029 from $17 billion in 2019, according to analyst firm Jefferies.  The firm’s estimate includes the Canadian markets, the United States’ thirty-three medicinal markets and seventeen recreational markets, Europe’s twelve-country medical market, Latin America’s five-country medical and 2-country recreational market as well as three other countries with a legal medical market.

cannabisstocks.jpg

Jefferies analyst Owen Bennett, Jefferies analyst believes that the firm’s projection is “probably conservative,” and that a “realistic upside scenario” may be a global cannabis market as large as $130 billion by 2029. “This assumes full U.S. federal legalization, full recreational and medical legalization across Europe, full medical and recreational legalization across Lat Am, and cannabis disruption of a number of other industries,” Bennett added.

While the cannabis industry continues to show strength and sentiment surrounding stocks in the sector remains positive, investors may continue to find opportunities in cannabis stocks.

ParcelPal Technology Inc. (PTNYF) (PKG) (FSE: PT0), a technology-driven logistics company purposed with connecting consumers to the goods they love within an hour, announced it will be hosting an investor update conference call on May 17th, 2019 to review recent progress. The company also announced that it will be releasing its quarterly financial statements for Q4 FY2018 by April 30, 2019.

This followed the news of achieving a major milestone, the completion of over 2 million deliveries.  The company’s plans to move forward include more joint ventures, expansion on its technology and to push its platform on multiple consumer verticals, while expanding operations across Canada and into the U.S. ParcelPal is in the final stages of launching medical and recreational cannabis delivery in Canada with Choom Holdings (CHOOF) and recently signed Kiaro.  This on-demand cannabis delivery plan is expected to begin in April 2019, with more details to follow, and is expected to drive additional users to the platform and open fresh markets.

President and CEO Kelly Abbott states, “We are extremely excited to have achieved this major milestone. Our growth in 2018 was tremendous and our team has grown significantly. We are looking forward to a successful rollout in the cannabis industry amongst other verticals in the coming months across Canada with existing and future partnerships.”

Aurora Cannabis Inc. (ACB) announced that the company has appointed Carey Squires as its Executive Vice President of Corporate Development and Strategy. In this newly created role, reporting to the Executive Chairman, Mr. Squires in collaboration with senior executives across

“With deep experience in the U.S. and Canadian capital markets, Carey has been a trusted advisor to Aurora on a variety of growth initiatives, including our recently successful capital raise,” said Michael Singer, Executive Chairman. “In this new position, Carey will be a core member of Aurora’s senior management team, executing on the development of key strategic initiatives, including partnerships and M&A opportunities. We look forward to working closely with Carey to leverage his extensive knowledge in the execution of our investor development, international growth and partnership strategies, sourcing potential accretive opportunities in the global cannabis industry and negotiating favourable business transactions.”

This followed the news of the filing on Tuesday of a preliminary short-form base shelf prospectus with Canadian securities regulators and a corresponding shelf registration statement on Form F-10 with the U.S. Securities and Exchange Commission.  When made effective, this will allow Aurora to issue stock offerings, debt securities, subscription receipts, units or warrants for an aggregate value of up to $750 million during a period of 25 months, according to the company.

Charlotte’s Web Holdings, Inc. (CWBHF) (CWEB), a market share leader in hemp-derived CBD extract products, reported financial results for Q4 and year ended December 31, 2018. Fourth quarter highlights included: retail doors increased over 80% to 3680 and 57% of revenue came from ecommerce, organic consolidated revenue growth of 71% to $21.5 million, and gross profit increased 63% to $16.3 million, or 76% of consolidated revenue. Highlights of 2018 Full Year Results included: organic revenue growth of 74% to $69.5 million, gross profit increased 75% to $52.3 million, and adjusted EBITDA decreased to 30% from 36% of consolidated revenue.

“During the fourth quarter we concentrated our efforts on completing the 2018 harvest and building product inventory to support growing consumer demand. Our 2018 harvest resulted in 675,000 pounds of raw hemp compared to 63,000 pounds in 2017. This inventory build ensures we are able to meet growing demand and supply the large national retail chains that are beginning to carry our products. In general, broader consumer awareness of the benefits of cannabinoids, namely cannabidiol (CBD) from hemp extract, is driving increased uptake in all product categories in our retail channels and e-commerce platform,” stated Hess Moallem, President and CEO.

Charlotte’s Web has been actively adding additional retail distribution customers and locations and recently surpassed 4,000 locations after national retail chains began carrying its products.  Several new products and formats are planned for 2019 in animal nutrition, wellness topicals and human consumables, according to the company.

marijuanastocks.jpeg


This Blog is an affiliate of MIDAM VENTURES LLC.  Midam has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Midam owns zero shares. Click Here For Full Disclaimer

3 Marijuana Stocks Making Headlines

North America is by far the leader of the cannabis industry, as it is not only the fastest growing region but also possesses the largest market share.  Canada became the first G7 nation to legalize adult-use recreational cannabis and the influx of United States legalizing one form or another of cannabis as well the passing of the 2018 US Farm Bill, which legalized hemp, is driving the growth of the sector. The two countries, together, command the global cannabis industry, which is forecast to hit $146.4 billion across the globe by 2025, with a compound annual growth rate of 34.6%, according to a Grand View Research report.

marijuana.jpg

The increased legalization of cannabis along with the growing utilization in several medical applications are key factors for driving the growth of the industry.   As the cannabis industry continues to evolve, there are several marijuana stocks making headlines.

Leafbuyer Technologies, Inc. (LBUY) announced that the number of Greenlight platform users has reached nearly 80,000, further to its recent release announcing Leafbuyer’s launch of the Greenlight app in Colorado and Oklahoma. The platform permits consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at participating dispensaries. Presently, the number of Leafbuyer dispensary clients with capabilities has grown to a total of 60, located throughout the states of California, Colorado, Oklahoma, and Michigan.

“The rapid geographic implementation of the Greenlight technology and the large number of users is encouraging. Developments are under way to bring new features to the platform that are expected to be a catalyst for continued revenue growth,” said Kurt Rossner, CEO of Leafbuyer. “We plan to expand the footprint further and optimize this technology to make it a staple in every legal market across the country.”

This news followed the announcement that Leafbuyer and Greenlight now integrate with Flowhub’s point of sale and compliance technology, giving customers have access to immediate, up-to-date menu information regarding product availability in dispensaries using Flowhub API and Leafbuyer platforms.

Curaleaf Holdings, Inc. (CURLF) (CURA.CN) on its recent earnings conference, company executives said CVS Health Corp (CVS) will start offering its Curaleaf Hemp lotions and transdermal patches in around 800 stores across the U.S. Today the company annouced the opening of its 23rd Florida dispensary as it continues to expand rapidly throughout the state. Curaleaf has the largest cannabis dispensary footprint in the US, now with 43 dispensaries across the country.

“As Curaleaf continues to deliver on its expansion strategy, we are well positioned to improve the quality of patients’ lives by providing access to safe top-quality cannabis products,” shared Joe Lusardi, Curaleaf CEO.

The dispensary includes the community’s first medical marijuana drive-thru. Curaleaf was the first in the state to introduce and test the drive-thru concept at its Palm Harbor dispensary and since has launched a second drive-thru in Orlando.   Today, Curaleaf also announced it will celebrate its grand opening on Thursday, March 21 from 3pm until 7pm at its Gainesville dispensary.

Canopy Growth Corporation (CGC) (WEED) announced it has acquired AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, to accelerate Canopy Growth’s entry into key American jurisdictions. As previously mentioned, Canopy Growth is on track to build the first Hemp Industrial Park in the Southern Tier of New York State, after receiving a state license to produce and process hemp. Canopy growth committed to invest $100M to $150M into a hemp operation as well as the production of high-quality CBD products.

“The United States is the next stop on Canopy Growth’s desired path to becoming a leading, revenue-generating company focused on all aspects of cannabinoids and their potential,” said Bruce Linton, co-CEO and Chairman. “Our significant investments, acquisitions and compilation of talented leaders such as Geoff will position us for swift expansion throughout the United States. By collaborating with a pioneer like Geoff, who has been involved with our team since our earliest days in 2013, we will aim to turn hemp supplied by American farmers into a wide range of products.”

This news followed Canopy’s announcement earlier this week of a two-year processing and extraction agreement Wednesday with HollyWeed Manufacturing & Extracts Inc.  The agreement entails that HollyWeed will process Canopy-supplied dried cannabis flower in its and in turn, HollyWeed will supply Canopy with oil and resin extracted from the source material. The companies expect the first shipment of product for extraction will take place in fall of 2019.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018 and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam owns 77,000 shares of Leafbuyer Technologies. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

3 Marijuana Stocks To Add To Your Watch-List This Week

The marijuana market has been really budding over the last few years, especially with the recent monumental legislature that has been passed in North America. It seems to be a promising time for marijuana companies. Last year’s legalization of recreational pot in Canada and California, as well as the passing of the 2018 US Farm Bill which legalized hemp, may be setting the stage for more countries and/or states to “go green”.

cannabisstocks.jpg

As we see increased legalization of marijuana, whether medical or recreational, the potential to generate job opportunities and economic benefits rises. According to an Arcview Market Research and BDS Analytics report, consumer spending on legal cannabis is forecast to reach USD $11 billion this year and by 2022 it’s anticipated to surpass USD $23 billion.  Also, during that time period, the U.S. cannabis industry is expected to create over 467,000 full-time equivalent jobs, an 180% increase from 2017’s 170,000 full-time equivalent jobs. As the marijuana industry continues to grow at a rapid rate, there are several marijuana stocks to add to your watch-list.

Leafbuyer Technologies, Inc. (LBUY) announced the official launch of the leading mobile application Greenlight in Colorado and Oklahoma, further to the company’s announcement of the acquisition of Greenlight in November.  Previously, the order ahead app was only available in California and now 16 Leafbuyer dispensary clients in Colorado as well as 9 clients in Oklahoma have signed up. Through the Greenlight app, consumers can preorder their favorite cannabis products from participating dispensaries and skip the line when they go to pay and pick them up.

“In this fast-paced industry, we need to stay ahead of technology and continuously improve our offerings to drive more value to our clients,” said Kurt Rossner, CEO. “Greenlight is one more platform we have that separates us from our competition, inherently making Leafbuyer a more attractive option to dispensary clients nationwide.”

This news followed the announcement that Leafbuyer and its recently acquired mobile app, Greenlight, now integrates with Flowhub’s point of sale and compliance technology.   On both Leafbuyer.com and the Greenlight app, customers now have access to immediate, up-to-date menu information regarding product availability in dispensaries using Flowhub API and Leafbuyer platforms. Recently, the company has also signed over 50 licensed medical dispensaries within the Oklahoma market.

Tilray Inc (TLRY) is scheduled to announce Q4 earnings today March 18th after the closing bell.  The company recently announced the expansion of its global leadership team with the appointment of Andrew Pucher as Chief Corporate Development Officer. In his new role, Andrew will lead Tilray’s corporate development function, including the team that is responsible for M&A and corporate investments. He will be based in Toronto, ON, and report to CEO Brendan Kennedy.

Brenden Kennedy, CEO of said, “we’re pleased to welcome Andrew to our senior leadership team to execute strategic transactions that will further accelerate Tilray’s long-term global growth. Andrew shares our commitment to a disciplined, strategic approach in pursuing inorganic growth opportunities.

Last week, Tilray and LiveWell Canada annouced finalizing their agreement for the supply of hemp cannabidiol (CBD) to Tilray. Under the deal, LiveWell will supply Tilray with a monthly quantity of up to 300 kilograms of hemp-derived CBD isolate, or an equivalent amount of full-spectrum CBD extract. It includes an option to increase to 500 kilograms per month. Shipping will begin in Q2.

Aurora Cannabis Inc (ACB) announced last week that it has appointed Nelson Peltz as a Strategic Advisor. Mr. Peltz and Aurora will work collaboratively and strategically to explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora’s contemplated market segments and advise on the company’s global expansion strategy.

“Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us,” said Terry Booth. “Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders. We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact.”

This news followed the launch of sales of cannabis oils to German pharmacies following receipt of all necessary approvals from the Canadian and German regulatory authorities. Pedanios 5/1 drops have become the first extract derived oil product compliant with the German monograph for in-pharmacy preparation.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018 and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam owns 77,000 shares of Leafbuyer Technologies. Midam may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc.